We are live on
!
Find out more
Eli Lilly
2,481 hedge funds and large institutions have $257B invested in Eli Lilly in 2022 Q3 according to their latest regulatory filings, with 157 funds opening new positions, 939 increasing their positions, 935 reducing their positions, and 85 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
more capital invested
Capital invested by funds: $ → $
0.74% more ownership
Funds ownership: 82.92% → 83.66% (+0.74%)
0% more repeat investments, than reductions
Existing positions increased: 939 | Existing positions reduced: 935
5% less call options, than puts
Call options by funds: $2.43B | Put options by funds: $2.55B
Holders
2,481
Holding in Top 10
188
Calls
$2.43B
Puts
$2.55B
Top Buyers
| 1 | +$1.4B | |
| 2 | +$1.11B | |
| 3 | +$586M | |
| 4 |
VOYA Investment Management
Atlanta,
Georgia
|
+$424M |
| 5 |
Amundi
Paris,
France
|
+$367M |
Top Sellers
| 1 | -$644M | |
| 2 | -$505M | |
| 3 | -$431M | |
| 4 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$344M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$310M |